EGRX - Eagle Pharmaceuticals Inc.'s (EGRX) CEO Scott Tarriff on Q1 2021 Results - Earnings Call Transcript
Eagle Pharmaceuticals, Inc. (EGRX) Q1 2021 Earnings Conference Call May 10, 2021, 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Scott Tarriff - Chief Executive Officer Brian Cahill - Chief Financial Officer Conference Call Participants Tim Lugo - William Blair Daniel Busby - RBC Capital Markets David Amsellem - Piper Sandler Brandon Folkes - Cantor Fitzgerald Presentation Operator Good morning, everyone. My name is Leo, and I will be your conference operator. At this time, I’d like to welcome everyone to Eagle Pharmaceuticals’ First Quarter 2021 Financial Results Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period. [Operator Instructions] As a reminder, this conference is being recorded today, May 10, 2021. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead. Lisa
For further details see:
Eagle Pharmaceuticals, Inc.'s (EGRX) CEO Scott Tarriff on Q1 2021 Results - Earnings Call Transcript